Analyst Coverage

COMPANY ANALYST RECOMMENDATION TARGET PRICE TARGET PRICE LAST REVISION
R$
Banco do Brasil Luan Calimerio
55 11 4298-7000
Buy 9.60 05/13/2024
Bradesco BBI Victor Mizusaki
55 11 3847-9291
Outperform 18.00 02/20/2024
BTG Pactual Lucas Marquiori
55 11 3383 9119
Buy 11.00 05/28/2024
EQI Pedro Pimenta Buy 13,00 10/06/2023
Genial Investimentos Ygor Bastos de Araujo Buy 9.40 05/10/2024
Itaú BBA Daniel Gasparete
55 11 91434-5888
Outperform 7.50 06/25/2024
Jefferies Alejandro Demichelis
34 919498377
Hold 6.20 06/26/2024
J.P. Morgan Guilherme Mendes
55 11 4950-4105
Outperform 15.00 05/02/2024
Levante Chrystian Oliveira Buy 13.30 05/15/2024
Safra Luiz Peçanha
55 11 3175-4284
Outperform 24.00 06/07/20122
Santander Lucas Barbosa
55 11 3553-5320
Buy 18.00 08/05/2021
Suno José Eduardo Daronco  Buy 12.85 04/09/2024
XP Pedro Bruno Buy 18.40 08/24/2022
INTERNATIONAL FIXED INCOME COVERAGE
BANK CONTACT E-MAIL PHONE CITY
BTG Pactual Thomas Tenyi [email protected] +1-646-924-2477 NEW YORK
Citibank Miguel Garcia de Onrubia [email protected] +1-212-723-1014 NEW YORK
Debtwire Jonathan Szwarc [email protected] +1-212-574-7873 NEW YORK
Jefferies Alexander Monroy [email protected] +1-212-708-2756 NEW YORK
Jefferies LLC Nicolas Fabiancic [email protected]  +1-212-336-7239 NEW YORK
Lucror Analytics Soummo Mukherjee [email protected] +1-786-591-7987 FLORIDA
Mizuho Americas Humberto Garcia humberto.garcia@mizuhogroup.com +1 212 205 7716 NEW YORK
Nomura Vinicius Medeiros [email protected] +1-212-667-9485 NEW YORK
Santander Aaron Holsberg [email protected] +1-212-407-0978 NEW YORK
SMBC Nikko Roger Horn [email protected] +1-212-224-5332 NEW YORK
XP Investimentos Sergio Vailati [email protected] +55 (11) 3027-2335 SÃO PAULO

SIMPAR is covered by the analysts listed above. Please note that any opinions, estimates or forecasts regarding SIMPAR performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Company or its management. SIMPAR does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. The Company does not warrant that the above list of analysts is complete nor updated, and the information herein provided are subject to the authorization of the analysts.